Fox Run Management’s Nektar Therapeutics NKTR Stock Holding History

Fox Run Management’s Portfolio NKTR Stock Details NKTR Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$1.12M	Buy
2022 Q1	–	Sell
2021 Q4	$188K	Buy
2020 Q1	–	Sell
2019 Q4	$342K	Buy
2019 Q1	–	Sell
2018 Q4	$384K	Buy
2018 Q3	–	Sell
2018 Q2	$253K	Buy
2018 Q1	$209K	Buy